| Description | Sanazole is a 3-nitrotriazole cpd. It can affect the human cervical cancer cell line. |
| Synonyms | AK2123, AK-2123, AK 2123 |
| molecular weight | 229.19 |
| Molecular formula | C7H11N5O4 |
| CAS | 104958-90-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Sreeja S, Krishnan Nair CK. Tumor control by hypoxia-specific chemotargeting of iron-oxide nanoparticle - Berberine complexes in a mouse model. Life Sci. 2018 Feb 15;195:71-80. doi: 10.1016/j.lfs.2017.12.036. Epub 2017 Dec 28. PubMed PMID: 29289560. 2. Zeng YC, Wu R, Xiao YP, Xin Y, Chi F, Xing R, Xue M, Wang NQ. Radiation enhancing effects of sanazole and gemcitabine in hypoxic breast and cervical cancer cells in vitro. Contemp Oncol (Pozn). 2015;19(3):236-40. doi: 10.5114/wo.2015.51820. Epub 2015 Jun 2. PubMed PMID: 26557765; PubMed Central PMCID: PMC4631282. 3. Sreeja S, Nair CK. Anticancer Property of Iron Oxide Nanoparticle-Drug Complexes: An In Vitro Study. J Environ Pathol Toxicol Oncol. 2015;34(3):183-9. PubMed PMID: 26349601. 4. Nair GG, Nair CK. Sanazole directed targeting of silver nanoparticle drug complex to tumor mass: a preclinical investigation in murine model. J Cancer Res Ther. 2014 Oct-Dec;10(4):979-84. doi: 10.4103/0973-1482.148705. PubMed PMID: 25579540. |